Puma Biotechnology (PBYI) Other Non-Current Assets (2011 - 2026)

Puma Biotechnology has reported Other Non-Current Assets for 16 years, with the latest figure at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 40.71% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (up 40.71% YoY), and the FY2025 full-year result was $2.1 million, up 639.44% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $3.0 million, up from $2.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $3.3 million in Q1 2022, with the low at $217000.0 in Q3 2022.
• Historically, Other Non-Current Assets has averaged $2.2 million across 5 years, with a median of $2.3 million in 2023.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 93.45% — and 2023, when it jumped 1240.09%.
• Puma Biotechnology's Other Non-Current Assets stood at $2.6 million in 2022, then slipped by 2.59% to $2.5 million in 2023, then slumped by 88.75% to $284000.0 in 2024, then surged by 639.44% to $2.1 million in 2025, then soared by 40.71% to $3.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q2 2025), per Business Quant data.